Literature DB >> 33557692

Cerebrovascular phenotypes in mouse models of Alzheimer's disease.

Jenny I Szu1, André Obenaus2.   

Abstract

Alzheimer's disease (AD) is a devastating neurological degenerative disorder and is the most common cause of dementia in the elderly. Clinically, AD manifests with memory and cognitive decline associated with deposition of hallmark amyloid beta (Aβ) plaques and neurofibrillary tangles (NFTs). Although the mechanisms underlying AD remains unclear, two hypotheses have been proposed. The established amyloid hypothesis states that Aβ accumulation is the basis of AD and leads to formation of NFTs. In contrast, the two-hit vascular hypothesis suggests that early vascular damage leads to increased accumulation of Aβ deposits in the brain. Multiple studies have reported significant morphological changes of the cerebrovasculature which can result in severe functional deficits. In this review, we delve into known structural and functional vascular alterations in various mouse models of AD and the cellular and molecular constituents that influence these changes to further disease progression. Many studies shed light on the direct impact of Aβ on the cerebrovasculature and how it is disrupted during the progression of AD. However, more research directed towards an improved understanding of how the cerebrovasculature is modified over the time course of AD is needed prior to developing future interventional strategies.

Entities:  

Keywords:  Alzheimer’s disease; amyloid beta; cerebral amyloid angiopathy; cerebrovascular; transgenic mice

Mesh:

Substances:

Year:  2021        PMID: 33557692      PMCID: PMC8327123          DOI: 10.1177/0271678X21992462

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  142 in total

1.  Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study.

Authors:  M M Breteler
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 2.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 3.  Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?

Authors:  Alan I Faden; David J Loane
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

4.  Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy.

Authors:  Cheryl A Hawkes; Wolfgang Härtig; Johannes Kacza; Reinhard Schliebs; Roy O Weller; James A Nicoll; Roxana O Carare
Journal:  Acta Neuropathol       Date:  2011-01-23       Impact factor: 17.088

5.  Thrombin mediates severe neurovascular injury during ischemia.

Authors:  Bo Chen; Qun Cheng; Kai Yang; Patrick D Lyden
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

6.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

Review 7.  Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.

Authors:  Mitsuru Shinohara; Masaya Tachibana; Takahisa Kanekiyo; Guojun Bu
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

Review 8.  The vascular neural network--a new paradigm in stroke pathophysiology.

Authors:  John H Zhang; Jerome Badaut; Jiping Tang; Andre Obenaus; Richard Hartman; William J Pearce
Journal:  Nat Rev Neurol       Date:  2012-10-16       Impact factor: 42.937

9.  Altered angioarchitecture in selected areas of brains with Alzheimer's disease.

Authors:  V W Fischer; A Siddiqi; Y Yusufaly
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 10.  Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.

Authors:  M Nauck
Journal:  Diabetes Obes Metab       Date:  2016-01-05       Impact factor: 6.577

View more
  5 in total

Review 1.  Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.

Authors:  Hema Kumari Alajangi; Mandeep Kaur; Akanksha Sharma; Sumedh Rana; Shipali Thakur; Mary Chatterjee; Neha Singla; Pradeep Kumar Jaiswal; Gurpal Singh; Ravi Pratap Barnwal
Journal:  Mol Brain       Date:  2022-06-01       Impact factor: 4.399

2.  Chronic cerebral hypoperfusion and blood-brain barrier disruption in uninjured brain areas of rhesus monkeys subjected to transient ischemic stroke.

Authors:  Yingqian Zhang; Bangcheng Zhao; Qi Lai; Qinxi Li; Xun Tang; Yinbing Zhang; Zhixiang Pan; Qiang Gao; Zhihui Zhong
Journal:  J Cereb Blood Flow Metab       Date:  2022-02-09       Impact factor: 6.960

3.  Activated endothelial cells induce a distinct type of astrocytic reactivity.

Authors:  Xavier Taylor; Pablo Cisternas; Nur Jury; Pablo Martinez; Xiaoqing Huang; Yanwen You; Javier Redding-Ochoa; Ruben Vidal; Jie Zhang; Juan Troncoso; Cristian A Lasagna-Reeves
Journal:  Commun Biol       Date:  2022-03-29

Review 4.  Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.

Authors:  Daejin Lim; Jae-Ho Jeong; Juhyun Song
Journal:  CNS Neurosci Ther       Date:  2021-05-04       Impact factor: 5.243

5.  Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Amandine Jullienne; Ryan Quan; Jenny I Szu; Michelle V Trinh; Erik J Behringer; Andre Obenaus
Journal:  Biomedicines       Date:  2022-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.